Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NORBTEAEXP.NS Stock Summary
Top 10 Correlated ETFs
NORBTEAEXP.NS
In the News
NORBTEAEXP.NS Financial details
Company Rating
Sell
Market Cap
169.79M
Income
-11.45M
Revenue
61.32M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
91
Optionable
No
Shortable
Yes
Earnings
15 Nov 2023
P/E
77.19
Forward P/E
-
PEG
2.43
P/S
2.09
P/B
1.12
P/C
-
P/FCF
-
Quick Ratio
0.15
Current Ratio
0.43
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.96
EPS next Y
-
EPS next Q
-
EPS this Y
-178.26%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
9.61%
Revenue Q/Q
-37.51%
EPS Q/Q
-311.86%
-
-
-
-
SMA20
16.67%
SMA50
-
SMA100
27.27%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
0.06%
Gross Margin
101%
Oper. Margin
15%
Profit Margin
3%
Payout
-
Shs Outstand
11.75M
Shs Float
5.33M
-
-
-
-
Target Price
-
52W Range
6.8-15.95
52W High
-13.33%
52W Low
+116.67%
RSI
52
Rel Volume
0.16
Avg Volume
10.41K
Volume
1.7K
Perf Week
-2.99%
Perf Month
11.59%
Perf Quarter
1.96%
Perf Half Y
-8.45%
-
-
-
-
Beta
1.16181
-
-
Volatility
0.68%, 1.14%
Prev Close
-1.89%
Price
13
Change
-4.06%
NORBTEAEXP.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 4.18 | 4.16 | 6.34 | 5.08 | 6.62 | |
Net income per share | -0.38 | -1.37 | 1 | -0.23 | 0.18 | |
Operating cash flow per share | 0.46 | 0.25 | 1.99 | 0.5 | 0.86 | |
Free cash flow per share | -0.54 | -0.44 | 0.95 | -0.57 | -0.44 | |
Cash per share | 0.03 | 0.1 | 0.35 | 0.25 | 0.58 | |
Book value per share | 13.02 | 11.66 | 12.62 | 12.43 | 12.64 | |
Tangible book value per share | 13.02 | 11.66 | 12.62 | 12.43 | 12.64 | |
Share holders equity per share | 13.02 | 11.66 | 12.62 | 12.43 | 12.64 | |
Interest debt per share | 5.99 | 7.06 | 6.21 | 7.11 | 8.41 | |
Market cap | 62.28M | 41.64M | 68.29M | 75.79M | 94M | |
Enterprise value | 126.8M | 116.25M | 133.13M | 152.4M | 182.7M | |
P/E ratio | -13.86 | -2.59 | 5.8 | -28.45 | 44.37 | |
Price to sales ratio | 1.27 | 0.85 | 0.92 | 1.27 | 1.21 | |
POCF ratio | 11.41 | 14.4 | 2.91 | 12.87 | 9.32 | |
PFCF ratio | -9.9 | -8.15 | 6.09 | -11.31 | -18.14 | |
P/B Ratio | 0.41 | 0.3 | 0.46 | 0.52 | 0.63 | |
PTB ratio | 0.41 | 0.3 | 0.46 | 0.52 | 0.63 | |
EV to sales | 2.58 | 2.39 | 1.78 | 2.55 | 2.35 | |
Enterprise value over EBITDA | 17.02 | -34.08 | 5.38 | 15.55 | 10.67 | |
EV to operating cash flow | 23.23 | 40.19 | 5.67 | 25.87 | 18.12 | |
EV to free cash flow | -20.17 | -22.75 | 11.87 | -22.74 | -35.26 | |
Earnings yield | -0.07 | -0.39 | 0.17 | -0.04 | 0.02 | |
Free cash flow yield | -0.1 | -0.12 | 0.16 | -0.09 | -0.06 | |
Debt to equity | 0.42 | 0.55 | 0.45 | 0.53 | 0.61 | |
Debt to assets | 0.29 | 0.33 | 0.29 | 0.32 | 0.35 | |
Net debt to EBITDA | 8.66 | -21.88 | 2.62 | 7.82 | 5.18 | |
Current ratio | 0.27 | 0.46 | 0.41 | 0.43 | 0.5 | |
Interest coverage | -0.41 | -1.22 | 2.8 | 0.59 | 1.41 | |
Income quality | -1.43 | -0.19 | 1.82 | -2.91 | 2.99 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.01 | 0 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | -0.01 | -0.01 | -0.01 | 0 | 0 | |
Capex to operating cash flow | -2.15 | -2.77 | -0.52 | -2.14 | -1.51 | |
Capex to revenue | -0.24 | -0.16 | -0.16 | -0.21 | -0.2 | |
Capex to depreciation | -2.71 | -1.71 | -2.47 | -2.41 | -2.78 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.59 | 18.96 | 16.85 | 7.96 | 7.16 | |
ROIC | -0.01 | -0.04 | 0.08 | 0.02 | 0.03 | |
Return on tangible assets | -0.02 | -0.07 | 0.05 | -0.01 | 0.01 | |
Graham Net | -5.27 | -6.82 | -6.12 | -7.19 | -7.95 | |
Working capital | -50.28M | -18.9M | -19.67M | -22.9M | -22.7M | |
Tangible asset value | 155.48M | 139.24M | 149.81M | 146.08M | 148.49M | |
Net current asset value | -54.76M | -74.04M | -67.64M | -77.82M | -86.12M | |
Invested capital | 0.42 | 0.55 | 0.45 | 0.53 | 0.61 | |
Average receivables | 4.85M | 8.58M | 5.19M | 2.93M | 2.87M | |
Average payables | 2.28M | 3.27M | 4.74M | 4.91M | 4.15M | |
Average inventory | 7.8M | 6.9M | 5.73M | 7.97M | 11.64M | |
Days sales outstanding | 72 | 55.94 | 14.22 | 18 | 13.14 | |
Days payables outstanding | 77.29 | 130.92 | -2.15K | -485.4 | -1.1K | |
Days of inventory on hand | 296.01 | 176.71 | -2.32K | -1.06K | -4.07K | |
Receivables turnover | 5.07 | 6.52 | 25.67 | 20.28 | 27.78 | |
Payables turnover | 4.72 | 2.79 | -0.17 | -0.75 | -0.33 | |
Inventory turnover | 1.23 | 2.07 | -0.16 | -0.35 | -0.09 | |
ROE | -0.03 | -0.12 | 0.08 | -0.02 | 0.01 | |
Capex per share | -1 | -0.68 | -1.04 | -1.07 | -1.3 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.8 | 0.62 | 1.52 | 1.93 | 1.19 | |
Net income per share | -0.18 | -0.4 | 0.1 | 0.59 | -1.25 | |
Operating cash flow per share | 0.21 | 0.27 | 0.23 | 0.24 | 0.26 | |
Free cash flow per share | 0.21 | 0.27 | 0.23 | 0.24 | 0.26 | |
Cash per share | 0 | 0.57 | 0 | 0.58 | 0 | |
Book value per share | 0 | 12.47 | 0 | 13.43 | 0 | |
Tangible book value per share | 0 | 12.47 | 0 | 13.43 | 0 | |
Share holders equity per share | 0 | 12.47 | 0 | 13.43 | 0 | |
Interest debt per share | 0.32 | 7.84 | 0.15 | 8.2 | 0.31 | |
Market cap | 92.83M | 95.24M | 84.67M | 135.23M | 131.6M | |
Enterprise value | 92.83M | 183.94M | 84.67M | 225.87M | 131.6M | |
P/E ratio | -11.25 | -4.98 | 18.38 | 4.92 | -2.24 | |
Price to sales ratio | 4.5 | 12.89 | 4.85 | 6.02 | 9.38 | |
POCF ratio | 38.68 | 30.04 | 31.36 | 48.3 | 42.98 | |
PFCF ratio | 38.68 | 30.04 | 31.36 | 48.3 | 42.98 | |
P/B Ratio | 0 | 0.64 | 0 | 0.86 | 0 | |
PTB ratio | 0 | 0.64 | 0 | 0.86 | 0 | |
EV to sales | 4.5 | 24.89 | 4.85 | 10.06 | 9.38 | |
Enterprise value over EBITDA | 33.65 | 197.15 | 19.81 | 20.9 | -13.67 | |
EV to operating cash flow | 38.68 | 58.03 | 31.36 | 80.67 | 42.98 | |
EV to free cash flow | 38.68 | 58.03 | 31.36 | 80.67 | 42.98 | |
Earnings yield | -0.02 | -0.05 | 0.01 | 0.05 | -0.11 | |
Free cash flow yield | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | |
Debt to equity | 0 | 0.61 | 0 | 0.59 | 0 | |
Debt to assets | 0 | 0.35 | 0 | 0.35 | 0 | |
Net debt to EBITDA | 0 | 95.07 | 0 | 8.39 | 0 | |
Current ratio | 0 | 0.5 | 0 | 0.77 | 0 | |
Interest coverage | 0.43 | -0.23 | 1.65 | 3.72 | -3.02 | |
Income quality | -1.16 | -0.66 | 2.34 | 0.41 | -0.21 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 10.62 | 0 | 13.35 | 0 | |
ROIC | 0 | 0 | 0 | 0.04 | 0 | |
Return on tangible assets | 0 | -0.02 | 0 | 0.03 | 0 | |
Graham Net | 0 | -7.84 | 0 | -7.81 | 0 | |
Working capital | 0 | -22.7M | 0 | -8.43M | 0 | |
Tangible asset value | 0 | 148.49M | 0 | 156.52M | 0 | |
Net current asset value | 0 | -86.12M | 0 | -80.94M | 0 | |
Invested capital | 0 | 0.61 | 0 | 0.59 | 0 | |
Average receivables | 3.43M | 1.4M | 1.4M | 2M | 2M | |
Average payables | 1.11M | 1.72M | 1.72M | 2.48M | 2.48M | |
Average inventory | 5.81M | 6.35M | 6.35M | 8.83M | 8.83M | |
Days sales outstanding | 0 | 34.09 | 0 | 16.06 | 0 | |
Days payables outstanding | 0 | -61.48 | 0 | -103.74 | 0 | |
Days of inventory on hand | 0 | -226.49 | 0 | -368.85 | 0 | |
Receivables turnover | 0 | 2.64 | 0 | 5.61 | 0 | |
Payables turnover | 0 | -1.46 | 0 | -0.87 | 0 | |
Inventory turnover | 0 | -0.4 | 0 | -0.24 | 0 | |
ROE | 0 | -0.03 | 0 | 0.04 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
NORBTEAEXP.NS Frequently Asked Questions
What is Norben Tea & Exports Limited stock symbol ?
Norben Tea & Exports Limited is a IN stock and trading under the symbol NORBTEAEXP.NS
What is Norben Tea & Exports Limited stock quote today ?
Norben Tea & Exports Limited stock price is $13 today.
Is Norben Tea & Exports Limited stock public?
Yes, Norben Tea & Exports Limited is a publicly traded company.